DOCSLIB.ORG

SYMPOSIUM 2019 19 & 20 September VELDHOVEN

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
SYMPOSIUM 2019 19 & 20 September VELDHOVEN ANNUAL SYMPOSIUM 2019 19 & 20 September VELDHOVEN Dutch Society for Human Genetics (www.nvhg-nav.nl) The NVHG encompasses two professional associations: the Dutch Association of Clinical Geneticists (Vereniging Klinische Genetica Nederland, VKGN), which unites medical specialists in clinical genetics, the Association of Clinical Genetic Diagnostic Laboratories (Vereniging Klinisch Genetische Laboratoriumdiagnostiek, VKGL) and the NACGG (Nederlandse Associatie voor Community Genetics en Public Health Genomics) which unites recognised clinical genetics laboratory specialists. Belgian Society for Human Genetics (www.beshg.be) The BeSHG represents the community of Belgian geneticists towards the other national and international Societies of Genetics, and provides a discussion forum on scientific, professional, social and ethical issues linked to the practice of human genetics. 1 Message from Dr. Mieke van Haelst, president NVHG and Prof. Dr. Gert Matthijs, president BeSHG Dear colleagues, Welcome to the second joint meeting of the Belgian and Dutch Society for Human Genetics. It is a pleasure to welcome you in Veldhoven! Both societies are characterized by a genuine interest in research in human genetics in combination with a strong clinical and societal commitment. Implementation of the scientific results to improve human health is an everyday goal for the majority of genetic researchers present at this meeting. Many of us have combine research and clinical activities and obligations, and our PhD students and post-docs are often implicated in research that stems from clinical observations or deals with patients’ material. Human genetics is a broad field, with a myriad of research opportunities and clinical applications. Our professional societies play a role in promoting scientific research in genetics and genomics, in its broadest sense. A lot is going on, and clearly, by your attendance, you witness that you wish to be part of these great times for human genetics. We are pleased to offer you a star-studded line-up of plenary speakers covering exiting developments in our field. John van der Oost will teach us about CRISPR-Cas, and guide us through a plethora of applications that have changed the world of genetic research and are finding their way to clinical application. Douglas Easton is a global leader in breast cancer genetics research and will focus on the use of polygenic risk score (PRS) in daily clinical practice. Michel Georges is a well-known leader in the field of animal genetics, but his work also reaches into the realms of human genetics, where he made important contributions to better understand GWAS loci 2 in Inflammatory Bowel Disease. Monogenic diseases – or what we believe are monogenic diseases- are discussed by Elfride De Baere who studies inherited retinal diseases and will show how integrated omics lead to better diagnosis and therapeutic applications for specific types of blindness. Joris Veltman, whom we know from pioneering novel genomic technologies, will focus on clinical outcomes that provide more insight into the success of assisted reproductive technologies, as well as the health of future offspring. Malte Spielmann studies genetics from yet another angle: structural variation in 3D. In his lecture, he will show us how the field is revolutionized with the study of genomes at the single cell level. Lisanne Vervoort is our youngest invited speaker. She will bring a wonderful story about the optical mapping of structural variation. Finally, we are very happy to have Peter de Knijff to entertain us about what he has learned during his 25 year journey in forensic genetic research. The program also focusses on the challenges we all face. In the interactive panel-discussion on ‘Hurdles for genetic research – what can we do about it?’ we will collectively explore specific issues that either affect or impede genetic research and clinical services, including diagnostics. We are all familiar with GDPR (in Dutch: AVG), ethical review procedures, and FAIR data, but really how does it affect our work? We look forward to interacting with the audience and learn also from your experiences. Finally, we are proud to announce that Danielle Posthuma has been awarded the Lodewijk Sandkuijl price for her ground-breaking work in Complex Genetics and she will enlighten us about her work in her lecture “From GWAS to Function”. We sincerely thank all the participants for their contribution. From the abstracts, the Scientific Committee has been able to select high quality presentations. Unfortunately we have not been able to offer all abstract submitters a slot in the program, so please also visit the posters. We also thank the sponsors, not only for their essential and generous financial contribution for the organization of the meeting, but also because they join us to present their latest innovations. This interaction between users and providers is very valuable, for all, but mostly for young people and trainees in the labs. Importantly, we wish to sincerely thank all the members that actively engage, in the organization and function of our Societies. We are happy we can count on you to make our societies thrive! We hope that this year’s meeting will bring you many new ideas and inspiring new collaborations. Mieke van Haelst, president NVHG Gert Matthijs, president BeSHG 3 General information Venue Hotel NH Eindhoven Conference Centre Koningshof Locht 117, 5504 RM Veldhoven Eindhoven - Nederland Tel.: +31 40 253 7475 www.nh-hotels.nl/hotel/nh-eindhoven-conference-centre-koningshof [email protected] Registration Holland Foyer: open on Thursday September 19, 2019 09:30 - 10:30hrs Reception and catering Holland foyer Networking event Brabantzaal Abstracts Abstracts guest speakers G 01 to G 08 Abstracts talks: T 01 to T 16 Abstracts posters : P 01 to P 39 Abstracts T 01 - T 16 and P 01 - P 31 are available as download through the NVHG website For abstracts of the NACGG, VKGN and VKGL sessions we refer to these societies and the NVHG website Posters Poster boards have a size of 200 cm (height) and 100 cm (width) Please put up your poster immediately after arrival. Do not forget to remove it at the end of the meeting Language The official language of the annual meeting will be English Accreditation Accreditation forms are available at the registration desk (GAIA ID number: 370535) Photos Photographs will be taken during the meeting which can be used by the NVHG for PR purposes. Anybody objecting should list their name on the form available at the NVHG registration desk. Badges You are requested to hand in your badge at the end of the symposium Presentations You are requested to timely hand in an USB stick with your presentation to the chairperson of your symposium session 4 Organization Scientific organization NVHG board Dr. Mieke van Haelst (President) Prof. dr. Johan den Dunnen (Secretary) Dr. ir. Aimée Paulussen (Treasurer) Dr. Terry Vrijenhoek Dr. Lidewij Henneman Dr. Roland Kuiper Prof. dr. Richard Sinke Prof. dr. André Uitterlinden Dr. Lisenka Vissers Dr. Gijs Santen BeSHG board Prof. dr. Gert Matthijs (President) Prof. Dr. Nisha Limaye (Secretary) Dr. Lut Van Laer (Treasurer) Dr. Saskia Bulk Prof. Dr. Bert Callewaert Prof. Dr. Kathelijn Keymolen Dr. Damien Lederer Dr. Julie Soblet Administrative organization Julia Lopez Hernandez ([email protected]) Henny Schurmann ([email protected]) www.nvhg-nav.n 5 Sponsors We are very grateful for the financial support from Simons Fund Foundation 6 We thank the following companies for their support: Golden Sponsors Agilent Technologies Moon www.agilent.com www.diploid.com/moon Illumina Takara Bio www.illumina.com www.takarabio.com Sophia Genetics SA PerkinElmer www.sophiagenetics.com www.perkinelmer.com/lifesciences 7 Silver Sponsors Sanofi Nimagen B.V. www.sanofigenzyme.nl www.nimagen.com Pacific Biosciences GE Healthcare www.pacb.com www3.gehealthcare.nl BIOKÉ B.V. BGI Global Genomic Services www.bioke.com www.bgi.com Twist Bioscience Sanbio www.twistbioscience.com www.sanbio.nl 8 Thermo Fisher Macrogen www.fishersci.nl dna.macrogen.com Westburg Hettich www.westburg.eu www.hettich.com Regular Sponsors Novogene Bionano Genomics en.novogene.com bionanogenomics.com Alnylan www.alnylam.com 9 Program Time Thursday 19th September 09:30 - 10:30 Registration Room: Holland Foyer 10:30 - 12:40 Opening & Plenary session 1 Room: Auditorium Chair: Mieke van Haelst (NVHG) / Saskia Bulk (BeSHG) 10:30 Opening by Dr. Mieke van Haelst president NVHG / Dr. Saskia Bulk board member BeSHG 10:35 Prof. Dr. John van der Oost (Wageningen, NL) CRISPR-Cas – from biology to applications 11:15 DNA Day Contest Award 11:20 Prof. Dr. Douglas Easton (Cambridge, UK) Predicting Breast Cancer Risk using Rare and Common Variants 12:00 Lodewijk Sandkuijl Lecture: Danielle Posthuma (Amsterdam, NL) From GWAS to Function 12:40 - 14:00 Lunch, room: Holland Foyer 13:00 Business/private meetings VKGN Room: Parkzaal 13:00 Business/private meetings VKGL Room: Auditorium 14:00 - 16:00 Plenary session 2 Room: Auditorium Chair: Terry Vrijenhoek (NVHG) / Bert Callewaert (BeSHG) Hurdles for genetic research - what can we do about them? Panel session to explore how genetic research could be further facilitated 14:00 Introduction session 14:15 Panel presentation and hurdle identification 15:00 Power Break 15:15 Plenary discussion - how to overcome the hurdles 15:45 Conclusion in images 10 16:00 - 17:30 Posters presentation with coffee & tea Room: 65 / Holland Foyer 17:30 - 18:30 Plenary session 3 Room: Auditorium Chair: Johan den Dunnen (NVHG) 17:30 Prof. Dr. Peter de Knijff (Leiden, NL) A result is only a result if it results in a result 18:30 - 21:00 Social Evening Program Room: Brabantzaal 18:30 Pre-dinner drinks 19:00 Dinner 21:00 Networking event Time Friday 20th September 08:30 - 09:30 Registration Room: Holland Foyer 08:45 - 10:05 Plenary session 4 Room: Auditorium Chair: André Uitterlinden (NVHG) / Saskia Bulk (BeSHG) 8:45 Prof.
Load more

Recommended publications
  • Psychostimulant-Regulated Plasticity in Interneurons of the Nucleus Accumbens
    Psychostimulant-Regulated Plasticity in Interneurons of the Nucleus Accumbens by David A. Gallegos Department of Neurobiology Duke University Date:_______________________ Approved: ___________________________ Anne E. West, Supervisor ___________________________ Jorg Grandl ___________________________ Debra Silver ___________________________ Gregory Crawford ___________________________ Hiro Matsunami Psychostimulant-Regulated Epigenetic Plasticity in Interneurons of the Nucleus Accumbens submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department of Neurobiology in the Graduate School of Duke University 2019 ABSTRACT Psychostimulant-Regulated Epigenetic Plasticity in Interneurons of the Nucleus Accumbens by David A. Gallegos Department of Neurobiology Duke University Date:_______________________ Approved: ___________________________ Anne E. West, Supervisor ___________________________ Jorg Grandl ___________________________ Debra Silver ___________________________ Gregory Crawford ___________________________ Hiro Matsunami An abstract of a dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department of Neurobiology in the Graduate School of Duke University 2019 Copyright by David Andres Gallegos 2019 Abstract Exposure to psychostimulant drugs of abuse exerts lasting influences on brain function via the regulation of immediate and persistent gene transcription. These changes in gene transcription drive the development of addictive-like
    [Show full text]
  • CSE642 Final Version
    Eindhoven University of Technology MASTER Dimensionality reduction of gene expression data Arts, S. Award date: 2018 Link to publication Disclaimer This document contains a student thesis (bachelor's or master's), as authored by a student at Eindhoven University of Technology. Student theses are made available in the TU/e repository upon obtaining the required degree. The grade received is not published on the document as presented in the repository. The required complexity or quality of research of student theses may vary by program, and the required minimum study period may vary in duration. General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain Eindhoven University of Technology MASTER THESIS Dimensionality Reduction of Gene Expression Data Author: S. (Sako) Arts Daily Supervisor: dr. V. (Vlado) Menkovski Graduation Committee: dr. V. (Vlado) Menkovski dr. D.C. (Decebal) Mocanu dr. N. (Nikolay) Yakovets May 16, 2018 v1.0 Abstract The focus of this thesis is dimensionality reduction of gene expression data. I propose and test a framework that deploys linear prediction algorithms resulting in a reduced set of selected genes relevant to a specified case. Abstract In cancer research there is a large need to automate parts of the process of diagnosis, this is mainly to reduce cost, make it faster and more accurate.
    [Show full text]
  • GWAS for Meat and Carcass Traits
    G3: Genes|Genomes|Genetics Early Online, published on July 11, 2019 as doi:10.1534/g3.119.400452 GWAS for meat and carcass traits using imputed sequence level genotypes in pooled F2- designs in pigs Clemens Falker-Gieske,*,1,2 Iulia Blaj,†,2 Siegfried Preuß,‡ Jörn Bennewitz,‡ Georg Thaller,† Jens Tetens*,§ *Department of Animal Sciences, Georg-August-University, 37077 Göttingen, Germany. †Institute of Animal Breeding and Husbandry, Kiel University, 24118 Kiel, Germany. ‡Institute of Animal Husbandry and Breeding, University of Hohenheim, 70599 Stuttgart, Germany. §Center for Integrated Breeding Research, Georg-August-University, 37077 Göttingen, Germany. 1 © The Author(s) 2013. Published by the Genetics Society of America. Running title: Sequence level GWAS in pooled F2 pigs Keywords Genome wide association study Whole genome sequencing Imputation Meat, carcass, and production traits Variant calling 1Corresponding author: Clemens Falker-Gieske, Georg-August-University Goettingen, Department of Animal Sciences, Division Functional Breeding, Burckhardtweg 2, 37077 Goettingen, (+49) 551-39-23669 2contributed equally. 2 ABSTRACT In order to gain insight into the genetic architecture of economically important traits in pigs and to derive suitable genetic markers to improve these traits in breeding programs, many studies have been conducted to map quantitative trait loci. Shortcomings of these studies were low mapping resolution, large confidence intervals for quantitative trait loci-positions and large linkage disequilibrium blocks. Here, we overcome these shortcomings by pooling four large F2 designs to produce smaller linkage disequilibrium blocks and by resequencing the founder generation at high coverage and the F1 generation at low coverage for subsequent imputation of the F2 generation to whole genome sequencing marker density.
    [Show full text]
  • SUPPLEMENTARY METHODS DNA Sequencing and Variant
    Supplementary material J Med Genet SUPPLEMENTARY METHODS DNA sequencing and variant identification Genomic DNA was isolated from peripheral blood lymphocytes following standard procedures. Subsequently, exome enrichment was performed using the Agilent SureSelect Human All Exome V5 kit according to the manufacturer’s protocols. Exome sequencing was performed on an Illumina HiSeq system by BGI Europe (Copenhagen, Denmark). Read mapping along the hg19 reference genome (GRCh37/hg19) and variant calling were performed using BWA V.0.78(1) and GATK HaplotypeCaller V.3.3(2). A coverage of >20 reads was reached for 85.1% to 97.8% of the enriched regions. For variant annotation an in-house developed annotation and variant evaluation pipeline was used. For sequencing data of family W97-056, CNV detection was performed using CoNIFER V.0.2.2.(3) Genome sequencing was performed by BGI (Hong Kong, China) on a BGISeq500 using a 2x 100 bp paired end module, with a minimal median coverage of 30-fold per genome. Structural variants were called using Manta V.1.1.0(4) and CNVs using Control-FREEC.(5) Variants were validated and visualized using the IGV Software (V.2.4).(6) In the index case of family W08-1421, targeted DNA sequencing was performed using MIP sequencing.(7) MIPs were designed covering exons and exon-intron boundaries of a panel of 89 HL genes (Supplementary Table 6). Sequencing and data analysis were performed as previously described.(8) For each targeted region, an average coverage of 420 reads was obtained. A coverage of >20 reads was reached for 85.4% of the MIPs.
    [Show full text]
  • Meta-Analysis of Gene Signatures and Key Pathways Indicates
    www.nature.com/scientificreports OPEN Meta‑analysis of gene signatures and key pathways indicates suppression of JNK pathway as a regulator of chemo‑resistance in AML Parastoo Modarres1, Farzaneh Mohamadi Farsani1,3, Amir Abas Nekouie2 & Sadeq Vallian1* The pathways and robust deregulated gene signatures involved in AML chemo‑resistance are not fully understood. Multiple subgroups of AMLs which are under treatment of various regimens seem to have similar regulatory gene(s) or pathway(s) related to their chemo‑resistance phenotype. In this study using gene set enrichment approach, deregulated genes and pathways associated with relapse after chemotherapy were investigated in AML samples. Five AML libraries compiled from GEO and ArrayExpress repositories were used to identify signifcantly diferentially expressed genes between chemo‑resistance and chemo‑sensitive groups. Functional and pathway enrichment analysis of diferentially expressed genes was performed to assess molecular mechanisms related to AML chemotherapeutic resistance. A total of 34 genes selected to be diferentially expressed in the chemo‑ resistance compared to the chemo‑sensitive group. Among the genes selected, c-Jun, AKT3, ARAP3, GABBR1, PELI2 and SORT1 are involved in neurotrophin, estrogen, cAMP and Toll‑like receptor signaling pathways. All these pathways are located upstream and regulate JNK signaling pathway which functions as a key regulator of cellular apoptosis. Our expression data are in favor of suppression of JNK pathway, which could induce pro‑apoptotic gene expression as well as down regulation of survival factors, introducing this pathway as a key regulator of drug‑resistance development in AML. Acute myeloid leukemia (AML) is one of the most aggressive, life-threatening hematological malignancies char- acterized by uncontrolled proliferation of abnormal diferentiated and nonfunctional myeloid precursor cells1.
    [Show full text]
  • Explorative Bioinformatic Analysis of Cardiomyocytes in 2D &3D in Vitro Culture System
    EXPLORATIVE BIOINFORMATIC ANALYSIS OF CARDIOMYOCYTES IN 2D &3D IN VITRO CULTURE SYSTEM VERSION 2 Master Degree Project in Bioscience One years Level, 60 ECTS Sruthy Janardanan [email protected] Supervisor: Jane Synnergren [email protected] Examiner: Sanja Jurcevic [email protected] Abstract The in vitro cell culture models of human pluripotent stem cells (hPSC)-derived cardiomyocytes (CMs) have gained a predominant value in the field of drug discovery and is considered an attractive tool for cardiovascular disease modellings. However, despite several reports of different protocols for the hPSC-differentiation into CMs, the development of an efficient, controlled and reproducible 3D differentiation remains challenging. The main aim of this research study was to understand the changes in the gene expression as an impact of spatial orientation of hPSC-derived CMs in 2D(two-dimensional) and 3D(three-dimensional) culture conditions and to identify the topologically important Hub and Hub-Bottleneck proteins using centrality measures to gain new knowledge for standardizing the pre-clinical models for the regeneration of CMs. The above-mentioned aim was achieved through an extensive bioinformatic analysis on the list of differentially expressed genes (DEGs) identified from RNA-sequencing (RNA-Seq). Functional annotation analysis of the DEGs from both 2D and 3D was performed using Cytoscape plug-in ClueGO. Followed by the topological analysis of the protein-protein interaction network (PPIN) using two centrality parameters; Degree and Betweeness in Cytoscape plug-in CenTiScaPe. The results obtained revealed that compared to 2D, DEGs in 3D are primarily associated with cell signalling suggesting the interaction between cells as an impact of the 3D microenvironment and topological analysis revealed 32 and 39 proteins as Hub and Hub-Bottleneck proteins, respectively in 3D indicating the possibility of utilizing those identified genes and their corresponding proteins as cardiac disease biomarkers in future by further research.
    [Show full text]
  • An RNA Switch of a Large Exon of Ninein Is Regulated by the Neural Stem Cell Specific-RNA Binding Protein, Qki5
    International Journal of Molecular Sciences Article An RNA Switch of a Large Exon of Ninein Is Regulated by the Neural Stem Cell Specific-RNA Binding Protein, Qki5 Yoshika Hayakawa-Yano and Masato Yano * Division of Neurobiology and Anatomy, Graduate School of Medical and Dental Sciences, Niigata University, 757, Ichibancho, Asahimachidori, Chuo-ku, Niigata, Niigata 951-8510, Japan; [email protected] * Correspondence: [email protected]; Tel.: +81-25-227-2054 Received: 10 January 2019; Accepted: 21 February 2019; Published: 26 February 2019 Abstract: A set of tissue-specific splicing factors are thought to govern alternative splicing events during neural progenitor cell (NPC)-to-neuron transition by regulating neuron-specific exons. Here, we propose one such factor, RNA-binding protein Quaking 5 (Qki5), which is specifically expressed in the early embryonic neural stem cells. We performed mRNA-SEQ (Sequence) analysis using mRNAs obtained by developing cerebral cortices in Qk (Quaking) conditional knockout (cKO) mice. As expected, we found a large number of alternative splicing changes between control and conditional knockouts relative to changes in transcript levels. DAVID (The Database for Annotation, Visualization and Integrated Discovery) and Metascape analyses suggested that the affected spliced genes are involved in axon development and microtubule-based processes. Among these, the mRNA coding for the Ninein protein is listed as one of Qki protein-dependent alternative splicing targets. Interestingly, this exon encodes a very long polypeptide (2121 nt), and has been previously defined as a dynamic RNA switch during the NPC-to-neuron transition. Additionally, we validated that the regulation of this large exon is consistent with the Qki5-dependent alternative exon inclusion mode suggested by our previous Qki5 HITS-CLIP (high throughput sequencing-cross linking immunoprecipitation) analysis.
    [Show full text]
  • Ernas and Superenhancer Lncrnas Are Functional in Human Prostate Cancer
    Hindawi Disease Markers Volume 2020, Article ID 8847986, 17 pages https://doi.org/10.1155/2020/8847986 Research Article eRNAs and Superenhancer lncRNAs Are Functional in Human Prostate Cancer Xiaona Zhang,1,2,3 Panpan Pang,2,3,4 Min Jiang,1,2,3 Qunfa Cao,2,3 Huili Li,2,3 Yi Xu,5 Yao Li ,4 Xue Chen ,1 and Junsong Han 2,3 1Department of Pathology, Tongji Hospital, Tongji University School of Medicine, Shanghai, China 2National Engineering Center for Biochip at Shanghai, Shanghai, China 3Shanghai Biochip Corporation, Shanghai, China 4Shanghai Engineering Research Center of Industrial Microorganisms, School of Life Science, Fudan University, Shanghai, China 5Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Chinese Medicine, Shanghai, China Correspondence should be addressed to Yao Li; [email protected], Xue Chen; [email protected], and Junsong Han; [email protected] Received 23 June 2020; Revised 27 July 2020; Accepted 14 August 2020; Published 24 September 2020 Academic Editor: Mingjun Shi Copyright © 2020 Xiaona Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Prostate cancer (PCa) is one of the most commonly diagnosed cancers in males worldwide. lncRNAs (long noncoding RNAs) play a significant role in the occurrence and development of PCa. eRNAs (enhancer RNAs) and SE-lncRNAs (superenhancer lncRNAs) are important elements of lncRNAs, but the role of eRNAs and SE-lncRNAs in PCa remains largely unclear. In this work, we identified 681 eRNAs and 292 SE-lncRNAs that were expressed differentially in PCa using a microarray.
    [Show full text]
  • Somatic Mutations in Early Onset Luminal Breast Cancer
    www.oncotarget.com Oncotarget, 2018, Vol. 9, (No. 32), pp: 22460-22479 Research Paper Somatic mutations in early onset luminal breast cancer Giselly Encinas1,*, Veronica Y. Sabelnykova2,*, Eduardo Carneiro de Lyra3, Maria Lucia Hirata Katayama1, Simone Maistro1, Pedro Wilson Mompean de Vasconcellos Valle1, Gláucia Fernanda de Lima Pereira1, Lívia Munhoz Rodrigues1, Pedro Adolpho de Menezes Pacheco Serio1, Ana Carolina Ribeiro Chaves de Gouvêa1, Felipe Correa Geyer1, Ricardo Alves Basso3, Fátima Solange Pasini1, Maria del Pilar Esteves Diz1, Maria Mitzi Brentani1, João Carlos Guedes Sampaio Góes3, Roger Chammas1, Paul C. Boutros2,4,5 and Maria Aparecida Azevedo Koike Folgueira1 1Instituto do Cancer do Estado de Sao Paulo, Departamento de Radiologia e Oncologia, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP, Brazil 2Ontario Institute for Cancer Research, Toronto, Canada 3Instituto Brasileiro de Controle do Câncer, São Paulo, Brazil 4Department of Medical Biophysics, University of Toronto, Toronto, Canada 5Department of Pharmacology and Toxicology, University of Toronto, Toronto, Canada *These authors have contributed equally to this work Correspondence to: Maria Aparecida Azevedo Koike Folgueira, email: [email protected] Keywords: breast cancer; young patients; somatic mutation; germline mutation; luminal subtype Received: September 26, 2017 Accepted: March 06, 2018 Published: April 27, 2018 Copyright: Encinas et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT Breast cancer arising in very young patients may be biologically distinct; however, these tumors have been less well studied.
    [Show full text]
  • Effective Prediction of Prostate Cancer Recurrence Through the IQGAP1 Network
    cancers Article Effective Prediction of Prostate Cancer Recurrence through the IQGAP1 Network Yan Gu 1,2,3, Xiaozeng Lin 1,2,3, Anil Kapoor 2,3,4 , Taosha Li 5, Pierre Major 6 and Damu Tang 1,2,3,* 1 Department of Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada; [email protected] (Y.G.); [email protected] (X.L.) 2 Urological Cancer Center for Research and Innovation (UCCRI), St Joseph’s Hospital, Hamilton, ON L8N 4A6, Canada; [email protected] 3 The Research Institute of St Joe’s Hamilton, St Joseph’s Hospital, Hamilton, ON L8N 4A6, Canada 4 Department of Surgery, McMaster University, Hamilton, ON L8S 4L8, Canada 5 Life-Tech Industry Alliance, Shenzhen 518000, China; [email protected] 6 Department of Oncology, McMaster University, Hamilton, ON L8S 4L8, Canada; [email protected] * Correspondence: [email protected]; Tel.: +1-905-522-1155 (ext. 35168) Simple Summary: Prostate cancer (PC) is a leading cause of cancer death in men in the developed countries. PC mortality is related to tumor relapse following curative therapy to primary tumors. It is thus essential to effectively assess the recurrence risk for personalized patient management. However, the current assessment capacity remains insufficient. We examined tumors produced in animals and samples derived from more than 1100 patients. A unique set of gene expression was observed following PC progression and a multigene panel consisting of 27 genes (Sig27gene) was constructed. Sig27gene is novel and robustly predicts PC relapse in two independent patient populations (n = 492 and n = 140) at p < 2 × 10−16. Sig27gene remains an independent risk factor of PC recurrence after adjusting for multiple clinical features.
    [Show full text]
  • Gene Expression Responses of Larval Gopher (Sebastes Carnatus) and Blue (S
    California State University, Monterey Bay Digital Commons @ CSUMB Capstone Projects and Master's Theses Capstone Projects and Master's Theses Fall 2020 Gene Expression Responses of Larval Gopher (Sebastes carnatus) and Blue (S. mystinus) Rockfish ot Ocean Acidification and Hypoxia Jacoby Baker Follow this and additional works at: https://digitalcommons.csumb.edu/caps_thes_all This Master's Thesis (Open Access) is brought to you for free and open access by the Capstone Projects and Master's Theses at Digital Commons @ CSUMB. It has been accepted for inclusion in Capstone Projects and Master's Theses by an authorized administrator of Digital Commons @ CSUMB. For more information, please contact [email protected]. GENE EXPRESSION RESPONSES OF LARVAL GOPHER (SEBASTES CARNATUS) AND BLUE (S. MYSTINUS) ROCKFISH TO OCEAN ACIDIFICATION AND HYPOXIA A Thesis Presented to the Faculty of Moss Landing Marine Laboratories California State University Monterey Bay In Partial Fulfillment of the Requirements for the Degree Master of Science in Marine Science by Jacoby Baker Fall 2020 CALIFORNIA STATE UNIVERSITY MONTEREY BAY The Undersigned Faculty Committee Approves the Thesis of Jacoby Baker: GENE EXPRESSION RESPONSES OF LARVAL GOPHER (SEBASTES CARNATUS) AND BLUE (S. MYSTINUS) ROCKFISH TO OCEAN ACIDIFICATION AND HYPOXIA Scott Hamilton, Chair Moss Landing Marine Laboratories Cheryl Logan, Primary Research Advisor California State Monterey Bay Jonathan Geller Moss Landing Marine Laboratories Nathaniel Jue California State Monterey Bay Daniel Shapiro, Interim Dean Associate VP for Academic Programs and Dean of Undergraduate and Graduate Studies 12/11/2020 Approval Date iii Copyright © 2020 by Jacoby Baker All Rights Reserved iv ABSTRACT Gene Expression Responses of Larval Gopher (Sebastes carnatus) and Blue (S.
    [Show full text]
  • Thousands of Cpgs Show DNA Methylation Differences in ACPA-Positive Individuals
    G C A T T A C G G C A T genes Article Thousands of CpGs Show DNA Methylation Differences in ACPA-Positive Individuals Yixiao Zeng 1,2, Kaiqiong Zhao 2,3, Kathleen Oros Klein 2, Xiaojian Shao 4, Marvin J. Fritzler 5, Marie Hudson 2,6,7, Inés Colmegna 6,8, Tomi Pastinen 9,10, Sasha Bernatsky 6,8 and Celia M. T. Greenwood 1,2,3,9,11,* 1 PhD Program in Quantitative Life Sciences, Interfaculty Studies, McGill University, Montréal, QC H3A 1E3, Canada; [email protected] 2 Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC H3T 1E2, Canada; [email protected] (K.Z.); [email protected] (K.O.K.); [email protected] (M.H.) 3 Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, QC H3A 1A2, Canada 4 Digital Technologies Research Centre, National Research Council Canada, Ottawa, ON K1A 0R6, Canada; [email protected] 5 Cumming School of Medicine, University of Calgary, Calgary, AB T2N 1N4, Canada; [email protected] 6 Department of Medicine, McGill University, Montréal, QC H4A 3J1, Canada; [email protected] (I.C.); [email protected] (S.B.) 7 Division of Rheumatology, Jewish General Hospital, Montréal, QC H3T 1E2, Canada 8 Division of Rheumatology, McGill University, Montréal, QC H3G 1A4, Canada 9 Department of Human Genetics, McGill University, Montréal, QC H3A 0C7, Canada; [email protected] 10 Center for Pediatric Genomic Medicine, Children’s Mercy, Kansas City, MO 64108, USA 11 Gerald Bronfman Department of Oncology, McGill University, Montréal, QC H4A 3T2, Canada * Correspondence: [email protected] Citation: Zeng, Y.; Zhao, K.; Oros Abstract: High levels of anti-citrullinated protein antibodies (ACPA) are often observed prior to Klein, K.; Shao, X.; Fritzler, M.J.; Hudson, M.; Colmegna, I.; Pastinen, a diagnosis of rheumatoid arthritis (RA).
    [Show full text]